Aims: To establish criteria of adequacy for bone marrow trephine biopsy specimens and to audit the quality of trephines performed at the Christie Hospital, Manchester. Methods: Trephines (n = 767) performed over 12 months were reviewed. Their lengths, and the lengths of their constituent parts (soft tissue, cortex, crushed marrow and interpretable marrow) were measured. The mean performance of each operator was calculated. Criteria of adequacy were established by a review of the published findings and an analysis of the relation between trephine length and the rate of infiltration by tumour. Results: Before processing, the average trephine was 159 cm long. 
The Christie Hospital, Manchester, is the regional referral centre for radiotherapy and chemotherapy for the north west of England. A large number of bone marrow trephines are therefore performed. It is impractical for these all to be carried out by members of the department of haematology, so the work is devolved to staff within each clinical department. This audit was undertaken because of a subjective impression within the department of histopathology that many of the trephine biopsy specimens received are of poor quality. Many appear to be small or show crush artefact. The aims of the audit were to establish criteria of adequacy and to substantiate or refute this subjective impression, to investigate reasons for inadequacy and to suggest remedies.
Methods
The study period ran from 1 June 1990 to 31 May 1991. The trephine biopsy specimens received in the histopathology department, both those performed within the Christie Hospital, and those sent from elsewhere for review, were ascertained from the department's day-book. Slides and request cards were retrieved from file. In the spring of 1991, a short questionnaire had also been distributed with the trephining equipment, asking the operator to record his name, the type of needle used and any problems experienced in performing the trephine biopsy; this information was incorporated in the study. It has been the practice for medical laboratory scientific officers (MLSOs) to record the lengths of trephine biopsy specimens after fixation and before paraffin wax embedding: this measurement is made with a metric rule. Where the MLSO recorded a trephine biopsy specimen as being in several pieces, the total length has been used in this study. The lengths of trephines in histological sections were also ascertained; again, where a trephine was in several pieces, the total length was recorded. Length of trephine biopsy specimen (cm) Figure 2 The percentage of trephine biopsy specimens positive for tumour plotted against the length of the trephine in 04 cm increments: 95% confidence limits for each bar are shown.
The average length of trephine biopsy specimen recorded by the MLSOs was 1X59 cm (95% cl 1X52-1*66 cm). The average total length of a trephine in histological section was 1-15 cm (c II10-I 19 cm). This amounted to an average shrinkage of 29% during processing and sectioning. The shrinkage was partly accounted for by the presence of blood clot on the trephine, which leads to an overestimate of the length of the trephine: in those 170 cases in which blood clot was present, the average length measured by MLSOs was greater, at 1-86 cm (cl 1-68-2-02 cm), with an average length in section of 1 16 cm (ci 1 07-1 24 cm), a shrinkage of 37%. However, even when no blood clot was seen in the section, there was an average shrinkage of 25%, from 1-51 cm (cl 1i44-1-57 cm) to 1-12 cm (cl 1-07-1-17 cm), during processing. All measurements given thereafter were made on histological sections and are therefore comparable; they should be multiplied by a factor of 1-33 to correct to the lengths before processing.
The average length of each component in histological section was: soft tissue 0 09 cm (c 1 0-07-011 cm); bone cortex 0 04 cm (cl 0 03-0 05 cm); disrupted marrow 0 26 cm (ci 0-24-028 cm); and interpretable marrow 0 74 cm (cl 0-70-0-78 cm). Hypocellular subcortex could only be identified with certainty in a small proportion of trephine biopsy specimens and its contribution to the average length was negligible; this component was not analysed further.
Thirty operators were identified who had performed more than five trephines during the study period. The average component lengths for each operator who had performed six or more trephines are shown in fig 1, ranked by the number of trephines performed. Figure 2 shows the proportion of trephines with marrow infiltration by tumour, plotted for 0-4 cm increments of the total trephine length. The proportion positive for tumour shows a rising curve to a plateau of about 30% at a length of at least 1 2 cm. A similar plot against the length of interpretable marrow showed a plateau at 08 cm. Similar curves, with the same threshold for the plateau are seen if trephines are restricted to 295 cases of nonHodgkin's lymphoma. No other specific diagnostic category was available in sufficient abundance for analysis. Because leukaemia affects the marrow more diffusely than other malignant neoplasms, the analysis was also performed on all cases of malignant neoplasia excluding 66 myeloid leukaemias; the shape of the curve was not significantly altered.
The relative merits of the Jamshidi and Islam needles were investigated. Data were available for 71 trephines known to have been performed with Jamshidi needles and 23 known to have been performed with Islam needles. The Jamshidi produced a trephine biopsy specimen which was on average 0-22 cm (cl -0-03-0 47 cm) longer, with ;ion
There is likely to be some variation as to arrow trephine biopsy is an important what constitutes adequacy, depending on the nent to marrow aspiration. For exam-spectrum of diseases in the patients from nshidi and Swain found that in which the trephine biopsy specimens are % of cases it yielded a diagnosis which obtained. We have therefore sought to establish apparent on the smear alone.' How-a minimum adequate length for the patient carry out many trephine biopsies is population treated at the Christie Hospital. re in terms of clinicians' and laboratory One would expect the proportion of trephine materials used, and in discomfort to biopsy specimens which are positive for These considerations, combined with tumour to increase with an increasing length of jective impression that many of the trephine, reaching a plateau for trephines of s are inadequate, makes it an appro-adequate length. This was indeed our finding ibject for medical audit. Bone marrow (fig 2) . We analysed the correlation between s are also unusual among histological positivity for tumour and trephine length for ns in that a simple numerical measure-specimens from a population of patients with a adequacy, the length of the trephine, variability in the individual trephines produced by any one operator, the proportion of adequate trephines from an operator rises sharply with the average length of trephine produced by that operator (fig 3) . We are aware that our hospital is unusual in the large number of operators, with a great variation among operators in their experience of performing trephines. Most hospitals will have fewer, more experienced, operators. This is reflected in the average length of the trephines produced outside of the Christie Hospital and sent to us for histological review (fig 1) , most of these being performed in district general hospitals by haematologists.
The subjective impression reported by operators is that the Jamshidi needle is superior to the Islam needle. This is the trend of our results, although the 95% confidence limits for the mean total and the mean useful lengths obtained with the two needles overlap.
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